Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular docking technology

Fig. 3

Enrichment of gene ontology (GO) and KEGG pathway of Epimedium in the treatment of depression. (A).Enriched GO terms for biological process (BP) of potential antidepressant targets from main active ingredients of Epimedium. (B). Enriched GO terms for the cellular component of potential antidepressant targets from main active ingredients of Epimedium.(C). Enriched GO terms for molecular function of potential antidepressant targets from main active ingredients of Epimedium. (D). Enriched KEGG pathways of potential antidepressant targets from main active ingredients of Epimedium

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us